Antimalarials have been used to treat rheumatoid arthritis (RA) for over 40 years, the first report of suggestive efficacy being published in 1951. Over the years they have become part of the established treatment of RA being one of a category of drugs referred to as disease modifying anti-rheumatic drugs (DMARDs). The onset of action with antimalarials is slow. Most patients use these drugs in combination with non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics. This article reviews the evidence for the efficacy of antimalarials, their place in comparison to other DMARDs and comments on the current use in RA as perceived in British rheumatology.
PageF.Treatment of lupus erythematosus with mepacrine.Lancet1951; 2: 755.
2.
HayduGG.Rheumatoid arthritis therapy: rationale and use of chloroquine diphosphate.Am J Med Sci1953; 2225: 71.
3.
BagnallAW.The value of chloroquine in rheumatoid disease - a four year study of continuous therapy.Can Med Assoc J1957; 77: 182.
4.
ScherbelAL, HarrisonJW, AtdjiamM.Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases.Cleve Clin Q1958; 25: 95.
5.
CohenAS, CalkinsE.A controlled study of chloroquine as an artirheumatic agent.Arthritis Rheum1958; 1: 297.
6.
RinehartRE, RosenbaumEE, HopkinsCE.Chloroquine therapy in rheumatoid arthritis.Northwest Med1957; 15: 251.
7.
FreedmanA.Chloroquine and rheumatoid arthritis. Short term controlled trial.Ann Rheum Dis1965; 152: 251.
8.
FreedmanA, SteinbergVL.Chloroquine in rheumatoid arthritis, a double blinded trial of treatment for one year.Ann Rheum Dis1960; 19: 243.
9.
PopertAJ, MeigersAKE, SharpJ, BierF.Chloroquine diphosphate in rheumatoid arthritis: a controlled study.Ann Rheum Dis1961; 20: 18.
10.
HamiltonEBD, ScottJT.Hydroxychloroquine sulfate (plaquenil) in the treatment of rheumatoid arthritis.Arthritis Rheum1962; 5: 502.
11.
MainlandD, SutcliffMI.Hydroxychloroquine sulfate in rheumatoid arthritis, a six month, double blind trial.Bull Rheum Dis1957; 13: 287.
12.
PavelkaKJr. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dosage regimens.Ann Rheum Dis1989; 48: 542–546.
13.
DwoshIL. Azathiaprine in early rheumatoid arthritis: comparison with gold and chloroquine.Arthritis Rheum1977; 20: 685–692.
14.
BunchTW, O'DuffyJD, TompkinsRB, O'FallonWH.Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis.Arthritis Rheum1984; 27: 267–76.
15.
FowlerPD, ShadforthMF, CrookPR, LawtonA.Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6 month comparative study.Ann Rheum Dis1984; 43: 200.
16.
BirdHA. A single blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis.Clin Rheumatol1984; 3 (Suppl 1): 57.
17.
Van der HeijdeDM. Effects of hydroxychloroquine and sulphasalazine on the progression of joint damage in rheumatoid arthritis.Lancet1989; 1: 1036.
18.
FelsonDT, AndersonJJ, MeenanRF.Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metanalysis of published clinical trials.Arthritis Rheum1992; 35: 1117–1125.
19.
DavisMJ. Should disease modifying agents be used in mild rheumatoid arthritis?Br J Rheumatol1991; 30: 451–454.
20.
YoussefW, YanA, RussellAS.Palindromic rheumatism: a response to chloroquine.J Rheumatol1991; 18: 35–37.
21.
KayEA, PullarT.Variations among rheumatologists in prescribing and monitoring of disease modifying artirheumatic drugs.Br J Rheumatol1992; 31: 477–483.
22.
BernsteinHN.Ocular safety of hydroxychloroquine.Ann Opthalmol1991; 23: 292–296.
